Trial Profile
Prospective, Randomized, Single-Blind, Placebo-Controlled, Dose-Escalation Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Subjects With Type II Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2018
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid/sodium ferrous citrate (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors SBI Pharmaceuticals Co Ltd
- 21 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Jun 2015 New trial record